Our Investment in WellTheory: The Virtual Care Platform for Autoimmune Disease

Accel announced its investment in WellTheory in this dated investment-related announcement. The announcement documents historical investment activity; it does not establish current ownership, a particular fund allocation or the amount attributable to Accel.